MAM
EXAS

Meeder Asset Management’s Exact Sciences EXAS Stock Holding History

Meeder Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-63
Closed -$6.4K – 938
2025
Q4 		$6.4K Hold
63
– – ﹤0.01% 756
2025
Q3 		$3.45K Buy
63
+13
+26% +$650 ﹤0.01% 728
2025
Q2 		$2.66K Buy
50
+9
+22% +$457 ﹤0.01% 793
2025
Q1 		$1.77K Sell
41
-15
-27% -$760 ﹤0.01% 872
2024
Q4 		$3.15K Sell
56
-8
-13% -$498 ﹤0.01% 877
2024
Q3 		$4.36K Sell
64
-16
-20% -$903 ﹤0.01% 766
2024
Q2 		$3.38K Buy
+80
New +$4.4K ﹤0.01% 815
2023
Q1 		– Sell
-408
Closed -$20.2K – 691
2022
Q4 		$20.2K Sell
408
-8,719
-96% -$356K ﹤0.01% 608
2022
Q3 		$296K Buy
9,127
+9,061
+13,729% +$374K 0.02% 490
2022
Q2 		$3K Sell
66
-40
-38% -$2.14K ﹤0.01% 1788
2022
Q1 		$7K Buy
+106
New +$7.75K ﹤0.01% 1671
2021
Q4 		– Sell
-5,968
Closed -$570K – 1547
2021
Q3 		$570K Buy
5,968
+562
+10% +$59.3K 0.03% 387
2021
Q2 		$672K Buy
5,406
+1,001
+23% +$119K 0.03% 370
2021
Q1 		$580K Buy
4,405
+4,338
+6,475% +$594K 0.03% 407
2020
Q4 		$9K Sell
67
-5,002
-99% -$605K ﹤0.01% 1021
2020
Q3 		$516K Sell
5,069
-1,123
-18% -$97K 0.03% 354
2020
Q2 		$538K Buy
6,192
+5,366
+650% +$429K 0.04% 347
2020
Q1 		$48K Sell
826
-7,403
-90% -$601K ﹤0.01% 927
2019
Q4 		$760K Sell
8,229
-3,578
-30% -$315K 0.05% 309
2019
Q3 		$1.07M Buy
11,807
+492
+4% +$56.1K 0.07% 231
2019
Q2 		$1.33M Buy
11,315
+3,721
+49% +$375K 0.09% 188
2019
Q1 		$657K Buy
7,594
+4,684
+161% +$399K 0.05% 333
2018
Q4 		$184K Buy
2,910
+2,496
+603% +$171K 0.02% 516
2018
Q3 		$32K Buy
414
+46
+13% +$3K ﹤0.01% 904
2018
Q2 		$22K Sell
368
-59
-14% -$3.17K ﹤0.01% 944
2018
Q1 		$17K Sell
427
-2,513
-85% -$123K ﹤0.01% 927
2017
Q4 		$155K Buy
2,940
+771
+36% +$41.2K 0.01% 497
2017
Q3 		$102K Buy
2,169
+923
+74% +$37.2K 0.01% 559
2017
Q2 		$44K Buy
1,246
+1,093
+714% +$33.7K ﹤0.01% 695
2017
Q1 		$4K Buy
+153
New +$3.03K ﹤0.01% 1154
2016
Q1 		– Sell
-2,108
Closed -$19K – 865
2015
Q4 		$19K Buy
+2,108
New +$19.6K ﹤0.01% 741
2015
Q2 		– Sell
-84,275
Closed -$1.86M – 492
2015
Q1 		$1.86M Buy
84,275
+66,920
+386% +$1.7M 0.2% 153
2014
Q4 		$476K Buy
+17,355
New +$422K 0.06% 328

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Meeder Asset Management's EXAS Position: Q1 2026 in Review

Meeder Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 63 shares — an estimated $6.4K sold.

Meeder Asset Management first reported a position in EXAS in Q4 2014 and held it in 33 quarters. The position peaked at $1.86M in Q1 2015. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Meeder Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Meeder Asset Management sold 63 Exact Sciences shares in Q1 2026, an estimated $6.4K.
  • Meeder Asset Management first reported a position in Exact Sciences in Q4 2014 and held it in 33 quarters.
  • Meeder Asset Management's Exact Sciences position peaked at $1.86M in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Meeder Asset Management's 13F filing for Q1 2026, filed 7 May 2026.